publication venue for
- Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events.. 11. 2023
- Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models.. 11. 2023
- Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition.. 10. 2022
- Moving beyond conventional stratified analysis to assess the treatment effect in a comparative oncology study.. 9. 2021
- Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study.. 9. 2021
- Impact of COVID-19 on patients with rheumatic complications of cancer immunotherapy: results of a registry survey.. 8. 2020